<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904658364-novartis-announces-expansion-of-community-health-programs-to-close-gaps-in-heart-disease-and-cancer-care-targeting-more-than-30-countries-by-2030</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-09T05:15:00+00:00</news:publication_date>
        <news:title>Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904658390-basilea-erh-lt-zus-tzliche-usd-6-mio-von-carb-x-f-r-die-klinische-entwicklung-des-antibiotikums-bal2420</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-09T05:15:00+00:00</news:publication_date>
        <news:title>Basilea erhält zusätzliche USD 6 Mio. von CARB-X für die klinische Entwicklung des Antibiotikums BAL2420</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904658595-basilea-awarded-additional-carb-x-funding-of-usd-6-million-to-support-the-clinical-development-of-antibiotic-bal2420</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-09T05:15:00+00:00</news:publication_date>
        <news:title>Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904642718-new-peer-reviewed-publication-highlights-evidence-of-mother-to-child-transmission-of-lyme-disease-bacteria-during-pregnancy-and-calls-for-urgent</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-09T04:00:00+00:00</news:publication_date>
        <news:title>New Peer-Reviewed Publication Highlights Evidence of Mother-to-Child-Transmission of Lyme Disease Bacteria During Pregnancy and Calls for Urgent Research</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/388871d3-1a1a-48cf-8ebf-c08773485acd/small/bay-area-logo-0425-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904610880-hutchmed-highlights-data-to-be-presented-at-aacr-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-09T00:00:00+00:00</news:publication_date>
        <news:title>HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904610741-vireo-growth-inc-announces-acquisition-of-the-hawthorne-gardening-company-from-the-scotts-miracle-gro-company</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T23:45:56+00:00</news:publication_date>
        <news:title>Vireo Growth Inc. Announces Acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904595526-nxera-pharma-achieves-second-development-milestone-in-collaboration-with-eli-lilly-targeting-metabolic-diseases</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T23:33:55+00:00</news:publication_date>
        <news:title>Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904595847-telix-strengthens-board-with-additional-director-appointments</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T22:44:20+00:00</news:publication_date>
        <news:title>Telix Strengthens Board with Additional Director Appointments</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904595627-capitale-hosts-750-guests-for-the-next-step-s-10-year-gala-raising-500-000-to-support-israel-medical-fund-center</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T22:04:00+00:00</news:publication_date>
        <news:title>CAPITALE HOSTS 750 GUESTS FOR THE NEXT STEP’S 10-YEAR GALA, RAISING $500,000 TO SUPPORT ISRAEL MEDICAL FUND CENTER</news:title>
      </news:news>
        <image:image>
          <image:loc>https://i.imgur.com/pOGgotG.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904581911-found-health-claims-evaluated-affordable-glp-1-weight-loss-medication-provider-with-free-online-insurance-check</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T21:25:19+00:00</news:publication_date>
        <news:title>Found Health Claims Evaluated: Affordable GLP-1 Weight Loss Medication Provider with Free Online Insurance Check</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Found-Health.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904581705-aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T21:00:00+00:00</news:publication_date>
        <news:title>Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f41706a5-9f61-4772-83f1-6aa50c660788/small/enable-injections-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904581691-fda-removes-partial-clinical-hold-on-macrogenics-linnet-study</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:30:00+00:00</news:publication_date>
        <news:title>FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904568361-polyrizon-ltd-announces-closing-of-3-5-million-registered-direct-and-private-placements</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:16:00+00:00</news:publication_date>
        <news:title>Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTZmNTJlZmItOTljMi00Y2I1LThjMTMtMGYwOTZiN2UxN2JiLTUwMDEyOTIyMy0yMDI2LTA0LTA4LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904568472-universal-door-meditation-center-hosts-free-public-celebration-of-awakened-zen-master-thich-dieu-thien-s-25-year-milestone-april-11-in-sugar-land</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:15:20+00:00</news:publication_date>
        <news:title>Universal Door Meditation Center Hosts Free Public Celebration of Awakened Zen Master Thich Dieu Thien&#39;s 25-Year Milestone April 11 in Sugar Land, Texas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afd79128-3253-46ac-9253-71e6bac13f23/small/udmc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904568203-avita-medical-secures-10-year-barda-agreement-worth-up-to-25-5m-to-bolster-u-s-burn-emergency-preparedness</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:10:00+00:00</news:publication_date>
        <news:title>AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567716-immucell-announces-a-28-4-increase-in-product-sales-in-q1-of-2026-based-on-preliminary-unaudited-sales-results</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567720-outset-medical-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567722-option-care-health-to-announce-first-quarter-2026-financial-results-and-host-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OWFhZTIwODktMDI1Ni00ZDcyLWEwMGItMGZmYzc2MWFiZmM0LTEwMTk5NzQtMjAyNi0wNC0wOC1lbg==/tiny/Option-Care-Health-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567728-crinetics-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff5e7cfa-b9fb-4679-8bf3-6e9d25207b83/small/crinetics-logo-trademark-jpg-1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567783-clover-health-to-report-first-quarter-2026-financial-results-on-may-6-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567977-rxsight-highlights-300-000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904568342-annexon-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904568377-kyntra-bio-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904568428-nexgel-reschedules-shareholder-update-conference-call-to-april-15th-at-4-30-p-m-et-to-provide-update-on-celularity-transaction</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:05:00+00:00</news:publication_date>
        <news:title>NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567669-inventiva-annonce-le-d-p-t-de-son-document-d-enregistrement-universel-2025-et-de-son-rapport-annuel-2025-form-20-f</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:00:00+00:00</news:publication_date>
        <news:title>Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2025 et de son Rapport Annuel 2025 (« Form 20-F ») </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567678-proqr-highlights-pipeline-expansion-and-multiple-upcoming-clinical-catalysts-at-investor-and-analyst-event</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:00:00+00:00</news:publication_date>
        <news:title>ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904567684-inventiva-announces-filing-of-its-2025-universal-registration-document-and-2025-annual-report-on-form-20-f</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T20:00:00+00:00</news:publication_date>
        <news:title>Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904554654-parker-university-women-s-volleyball-wins-2026-ncvf-national-championship</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T18:44:29+00:00</news:publication_date>
        <news:title>PARKER UNIVERSITY WOMEN’S VOLLEYBALL WINS 2026 NCVF NATIONAL CHAMPIONSHIP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjBkOWNmMWMtMWQ4NS00NmY4LWFjNDYtODBmZjAzMDhhNTc5LTEyMTMzODItMjAyNi0wNC0wOC1lbg==/tiny/Parker-University.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904554686-neura-supplement-claims-evaluated-the-7-second-red-goji-berry-recipe-memory-trick-for-neura-shield-cognitive-performance</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T18:41:48+00:00</news:publication_date>
        <news:title>Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Neura-Supplement.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904542286-ergodyne-readies-work-crews-for-the-dangers-of-warmer-temps</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T17:00:00+00:00</news:publication_date>
        <news:title>Ergodyne Readies Work Crews for the Dangers of Warmer Temps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NTgwMTM4MWQtYWIwOS00ZWIwLTlmMzAtYWExM2UyNDk3NTM5LTExODg4MTAtMjAyNi0wNC0wOC1lbg==/tiny/Ergodyne.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904542370-ascendis-pharma-to-list-ordinary-shares-directly-on-nasdaq</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T16:00:00+00:00</news:publication_date>
        <news:title>Ascendis Pharma to List Ordinary Shares Directly on Nasdaq</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904529759-trogenix-announces-publication-of-breakthrough-pre-clinical-data-in-nature-demonstrating-complete-tumour-eradication-and-durable-protection-in</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T15:02:54+00:00</news:publication_date>
        <news:title>Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/1df677d2-fb59-4859-a4a8-d74bdb945eca/small/trogenix-rgb-80-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904529871-new-23andme-research-institute-study-identifies-genetic-predictors-for-glp-1-weight-loss-efficacy-and-side-effects</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T15:00:00+00:00</news:publication_date>
        <news:title>New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e614a219-c44d-4fb3-8c94-b3a330509af9/small/23andme-ri-logo-stacked-color-min-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904530092-booking-health-releases-2026-report-on-advanced-head-and-neck-cancer-treatment-for-international-patients</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T14:50:00+00:00</news:publication_date>
        <news:title>Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3226262/1775134246_1024_depositphotos_844658038_xl-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904519657-steadman-philippon-research-institute-and-hospital-for-special-surgery-to-host-vail-hip-summit-april-9-11-at-four-seasons-resort-vail</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T14:00:05+00:00</news:publication_date>
        <news:title>Steadman Philippon Research Institute and Hospital for Special Surgery to Host Vail Hip Summit April 9–11 at Four Seasons Resort Vail</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZmRlMzIwMzQtOGY1Zi00MjQ0LTljNmYtNzM3ODFmMWM5NTkxLTExMDM2NjEtMjAyNi0wNC0wOC1lbg==/tiny/Steadman-Philippon-Research-In.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904519445-root-brands-addresses-the-glp-1-gap-with-crush-and-sculpt-a-science-driven-protocol-for-metabolic-and-muscle-support-after-ozempic-and-wegovy</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-08T13:41:42+00:00</news:publication_date>
        <news:title>ROOT Brands® Addresses the GLP-1 Gap with CRUSH and SCULPT, a Science-Driven Protocol for Metabolic and Muscle Support After Ozempic® and Wegovy®</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NGE2MTEwYWQtOWMzMy00YWU3LWFmZDMtZjQwNDRmNmI3NzRkLTUwMDE1MDU0NC0yMDI2LTA0LTA4LWVu/tiny/The-ROOT-Brands.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904518691-novabridge-reports-full-year-2025-financial-results-and-provides-business-update</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:50:00+00:00</news:publication_date>
        <news:title>NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364603-vtv-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:15:00+00:00</news:publication_date>
        <news:title>vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364649-voting-rights-and-shares-capital-of-the-company</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:15:00+00:00</news:publication_date>
        <news:title>Voting Rights and Shares Capital of the Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364730-information-mensuelle-relative-au-nombre-total-de-droits-de-vote-et-d-actions-composant-le-capital-social</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:15:00+00:00</news:publication_date>
        <news:title>Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364771-avita-medical-showcases-acute-burn-and-wound-care-portfolio-at-aba-2026-featuring-new-cohealyx-data</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:10:00+00:00</news:publication_date>
        <news:title>AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364829-as-easter-travel-triggers-bed-bug-infestation-warning-fantastic-pest-control-rolls-out-faster-more-efficient-low-pesticide-heat-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:06:00+00:00</news:publication_date>
        <news:title>As Easter Travel Triggers Bed Bug Infestation Warning Fantastic Pest Control Rolls Out Faster, More Efficient, Low-pesticide Heat Treatment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3226340/65c749bddbdcebd94903357da3d456ca_44_file.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364502-brightspring-health-services-inc-to-announce-first-quarter-2026-financial-results-on-may-1-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/db25f94c-83a2-46ba-8d53-c9a0768a71bd/small/brightspring-healthservices-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364525-vaxcyte-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364745-iridex-announces-new-partnership-with-eyeprogpo-to-expand-member-access-to-retina-laser-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364770-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:05:00+00:00</news:publication_date>
        <news:title>Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904364836-amneal-to-report-first-quarter-2026-results-on-may-1-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T20:01:00+00:00</news:publication_date>
        <news:title>Amneal to Report First Quarter 2026 Results on May 1, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904354949-lemaitre-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T18:39:10+00:00</news:publication_date>
        <news:title>LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904345601-mhm-invests-237-5-million-to-create-a-healthier-future-across-south-texas</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:47:05+00:00</news:publication_date>
        <news:title>MHM Invests $237.5 Million to Create a Healthier Future Across South Texas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjM4YmQ3ZDgtN2QzYy00MjdjLTk2ODQtNDllZjc1MjY2N2FiLTEyOTc4OTgtMjAyNi0wNC0wNy1lbg==/tiny/Methodist-Healthcare-Ministrie.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904345599-global-dna-read-write-and-edit-market-to-surge-to-67-7-billion-by-2030-driven-by-crispr-advances-genomic-diagnostics-and-expanding-clinical</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:44:41+00:00</news:publication_date>
        <news:title>Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904345591-gluco-zen-drops-under-investigation-safety-concerns-arise-amid-researching-the-ingredients-side-effects-risk-for-glucozen</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:35:22+00:00</news:publication_date>
        <news:title>Gluco Zen Drops Under Investigation: Safety Concerns Arise Amid Researching the Ingredients&#39; Side Effects Risk for GlucoZen</news:title>
      </news:news>
        <image:image>
          <image:loc>https://zingfast.com/wp-content/uploads/2026/04/Gluco-Zen-Drops.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904345226-genfit-announces-publication-of-the-2025-universal-registration-document</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:30:00+00:00</news:publication_date>
        <news:title>GENFIT Announces Publication of the 2025 Universal Registration Document   </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/YjA0MjRlZDQtMzQxZS00MDdhLTg3ZGEtZmVhOTQ4ZDQzZWI3LTEwMTEyNjgtMjAyNi0wNC0wNy1lbg==/tiny/GENFIT-S-A-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904345280-genfit-mise-disposition-du-document-d-enregistrement-universel-2025</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:30:00+00:00</news:publication_date>
        <news:title>GENFIT : Mise à disposition du Document d’Enregistrement Universel 2025   </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/YjA0MjRlZDQtMzQxZS00MDdhLTg3ZGEtZmVhOTQ4ZDQzZWI3LTEwMTEyNjgtMjAyNi0wNC0wNy1mcg==/tiny/GENFIT-S-A-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904345559-natural-remedies-awarded-american-botanical-council-s-2026-varro-e-tyler-commercial-investment-in-phytomedicinal-research-award</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T17:19:41+00:00</news:publication_date>
        <news:title>Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afb640f0-73d1-4cd2-bcbe-9a80b381d7cc/medium/2026-abc-varro-e-tyler-commercial-investment-in-phytomedicin.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904336536-coeptis-announces-approval-of-z-squared-inc-s-nasdaq-listing-application</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T16:05:56+00:00</news:publication_date>
        <news:title>Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6ef667b8-3767-4031-9180-f4ba33c81938/small/coeptis-logo-final-rgb-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904327021-heartfocus-and-inteleos-launch-first-ai-cardiac-pocus-certification</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T15:24:18+00:00</news:publication_date>
        <news:title>HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NTFkODg1MzItY2Q4MC00MTY2LTk4NjItODc1OTc1OTA4YjUyLTEyNDUwMzItMjAyNi0wNC0wNy1lbg==/tiny/Inteleos-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904326952-3-ways-pharmacists-can-help-maximize-your-glp-1-experience</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T15:01:15+00:00</news:publication_date>
        <news:title>3 Ways Pharmacists Can Help Maximize Your GLP-1 Experience</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/f72143cc-6829-468e-aeb9-94a8dbdcb874/17866-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904318679-speke-ai-to-showcase-ambient-ai-solutions-at-uca-s-2026-urgent-care-convention</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:37:17+00:00</news:publication_date>
        <news:title>Speke AI to Showcase Ambient AI Solutions at UCA’s 2026 Urgent Care Convention</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NTE3ZDRhZjgtMjgwNi00MGNkLThlOGItYmQwNzU4OTBiMDNkLTUwMDE1NDA4MS0yMDI2LTA0LTA3LWVu/tiny/Speke-AI.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904318654-nextel-medical-corp-announces-pivotal-milestone-in-commercial-launch-of-patent-protected-nanog-dna-cancer-screening-test</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:30:00+00:00</news:publication_date>
        <news:title>NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZmQ2OTkwNDMtN2QzOS00OWQ1LThhYzctYzg5MzFjMjgwODMwLTUwMDE1ODM1Mi0yMDI2LTA0LTA3LWVu/tiny/Exousia-Pro-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904318466-bioora-and-octane-biotech-sign-letter-of-intent-to-expand-cell-therapy-manufacturing-using-the-cocoon-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:15:00+00:00</news:publication_date>
        <news:title>BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YzFhYmQ1NzYtNzA3My00Y2JiLWE2MGQtMjM3ZDBmYzMxNTJhLTEzMDQwMTAtMjAyNi0wNC0wNy1lbg==/tiny/Octane-Medical-Group.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904318295-regional-health-properties-reports-fourth-quarter-2025-results</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:05:00+00:00</news:publication_date>
        <news:title>Regional Health Properties Reports Fourth Quarter 2025 Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bfd51062-4a60-4cf0-9f2f-a4b109b52e4a/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904318008-folia-health-launches-app-based-study-to-unlock-novel-real-world-evidence-of-symptom-burden-and-unmet-need-for-patients-and-caregivers-in-cidp</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T14:00:00+00:00</news:publication_date>
        <news:title>Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/858e11f4-96a0-4321-93eb-d278df849ccf/small/untitled-design-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904318126-inc-recognizes-u-s-oral-surgery-management-for-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:41:00+00:00</news:publication_date>
        <news:title>Inc. Recognizes U.S. Oral Surgery Management for Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904310228-merakris-therapeutics-provides-fda-update-and-reports-interim-findings-for-mtx-001-in-venous-leg-ulcers</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:30:00+00:00</news:publication_date>
        <news:title>Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b9c5fed-3332-4d4d-b8b6-6ab1b15faaed/small/mrks-brand-logo-final-fullcolor-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904310391-nurexone-biologic-s-u-s-subsidiary-exo-top-and-florida-based-bioxtek-sign-strategic-loi-for-exosome-manufacturing-and-commercialization</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:18:00+00:00</news:publication_date>
        <news:title>NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1514c671-cc84-4bcb-82d7-b834fce40882/small/nurexone-logo-rebrand-large-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904308717-cellution-biologics-inc-announces-official-entry-into-the-ocular-market-at-ascrs-with-the-launch-of-opticover</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:11:00+00:00</news:publication_date>
        <news:title>Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/10957e60-6696-483a-9df0-88f8713da811/medium/opticover.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904309254-srx-health-solutions-returns-5-69-in-march-2026-driven-by-emjx-artificial-intelligence-ai-engine</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:05:00+00:00</news:publication_date>
        <news:title>SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904310171-medx-holdings-reports-strong-q4-results-achieves-net-profitability-and-announces-strategic-partnerships-to-supercharge-franchise-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:05:00+00:00</news:publication_date>
        <news:title>MEDX HOLDINGS REPORTS STRONG Q4 RESULTS, ACHIEVES NET PROFITABILITY, AND ANNOUNCES STRATEGIC PARTNERSHIPS TO SUPERCHARGE FRANCHISE EXPANSION</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/995733cb-620f-4ea6-b204-8b5b5689df30/small/medx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904310583-treace-announces-first-surgical-cases-with-the-superbite-compression-screw-system</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:04:29+00:00</news:publication_date>
        <news:title>Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6f3a2631-2457-4100-950a-3dec602ec68d/medium/superbite-compression-screw-system.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904308778-saladax-biomedical-to-expand-international-access-to-drug-level-testing-for-psychiatry-and-oncology</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Saladax Biomedical to Expand International Access to Drug Level Testing for Psychiatry and Oncology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2NiMWYwYzAtNjA1My00OWFiLWFkN2ItZjY5YzgxNjE4MzI3LTUwMDEyNDYwOC0yMDI2LTA0LTA3LWVu/tiny/Saladax-Biomedical-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904308956-pathai-and-medstar-health-announce-partnership-to-deploy-the-aisight-dx-digital-pathology-platform-and-advanced-ai-applications</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ab2bfc12-ae80-47c6-9345-a98783489ed7/small/pathai-logo-standard-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904309046-death-by-a-thousand-vendors-81-of-employers-are-hiring-just-to-keep-up-with-digital-health-vendor-sprawl</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Death by a Thousand Vendors: 81% of Employers Are Hiring Just to Keep Up with Digital Health Vendor Sprawl</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b8d88974-2aeb-4baa-ad3b-2ab758ed4dd9/small/solera-main-logo-red-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904309197-lumin-health-appoints-matthew-mosquera-md-ms-as-regional-medical-director-and-site-director-of-lumin-cambridge</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb31fc23-dea3-476e-971b-6265973b0739/medium/matthew-mosquera.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904310148-ai-and-online-health-information-are-booming-but-americans-don-t-fully-trust-what-they-find</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T13:00:00+00:00</news:publication_date>
        <news:title>AI and Online Health Information Are Booming, But Americans Don’t Fully Trust What They Find</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NjE3YzhiYjItN2E5Yy00MjE5LWI1YTQtMGUzMmVlZjY3NzM2LTUwMDE2MDA3Mi0yMDI2LTA0LTA3LWVu/tiny/American-Association-of-Nurse-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904309350-outlook-therapeutics-announces-formal-dispute-resolution-request-for-ons-5010-lytenava-bevacizumab-vikg-accepted-by-fda</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:50:00+00:00</news:publication_date>
        <news:title>Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904309225-vivos-therapeutics-completes-private-placement-with-existing-private-equity-investor-new-seneca-partners</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:45:00+00:00</news:publication_date>
        <news:title>Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/22d07f60-2e17-421d-bbc3-748c2402061e/small/picture2-jpg.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904308798-moleculin-releases-next-ceo-corner-segment-highlighting-annamycin-s-non-cardiotoxic-profile</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:36:00+00:00</news:publication_date>
        <news:title>Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299971-20-20-biolabs-selected-by-evexia-diagnostics-to-offer-onetest-for-cancer-through-evexia-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:31:00+00:00</news:publication_date>
        <news:title>20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299756-xenon-to-highlight-phase-3-x-tole2-long-term-data-for-azetukalner-in-focal-onset-seizures-at-2026-aan-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Xenon to Highlight Phase 3 X-TOLE2 &amp; Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299796-abeona-therapeutics-announces-appointment-of-keith-a-goldan-to-its-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299918-clover-health-empowers-members-to-take-charge-of-their-health-data-through-healthex-partnership</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299951-integra-lifesciences-unveils-new-real-world-evidence-highlighting-primatrix-utilization</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/00cf1e29-7492-4f89-bab1-6691cf2253c4/medium/primatrix-dermal-scaffold.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299992-ss-innovations-to-host-smrsc-2026-in-new-delhi-india-from-april-9-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cef267e0-040f-4889-a706-cc4d0ae49e55/small/new-logo-april-23-2025-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300074-cormedix-to-participate-in-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CorMedix to Participate in Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300165-milestone-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300233-cdt-notes-sarborg-publication-of-prism-framework-expanding-ai</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:30:00+00:00</news:publication_date>
        <news:title>CDT Notes Sarborg Publication of PRISM Framework Expanding AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MjNiMmZlYjctZjk3NS00MWViLThkMjktZWUwZGQ1YzVkNzRjLTEyNzQxMDItMjAyNi0wNC0wNy1lbg==/tiny/CDT-Equity-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299831-biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:15:00+00:00</news:publication_date>
        <news:title>BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299713-nextcure-receives-fast-track-designation-for-sim0505-cdh6-adc-in-ovarian-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300472-emergent-biosolutions-launches-new-narcan-nasal-spray-carrying-case-and-multipacks-alongside-college-campus-outreach-to-expand-opioid-overdose</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:05:00+00:00</news:publication_date>
        <news:title>Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fcbfc65-93d7-475f-9f23-b47fbf2ab8ca/medium/narcan-nasal-spray-multipacks.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299511-evaxion-announces-last-patient-visit-in-one-year-extension-of-phase-2-trial-with-personalized-cancer-vaccine-evx-01</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299601-lyell-immunopharma-announces-participation-in-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299705-inhibikase-therapeutics-announces-enrollment-of-first-patient-in-improve-pah-global-phase-3-study-of-ikt-001-in-the-treatment-of-pulmonary-arterial</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299752-amneal-announces-2-million-donation-to-support-patient-access-to-essential-medicines-during-parkinson-s-awareness-month</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299830-crispr-therapeutics-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299833-gatc-health-and-uc-irvine-announce-landmark-pnas-publication-validating-ai-platform-for-opioid-use-disorder-treatment</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8252f5cc-6aca-4b39-b708-845c0ce98b86/small/color-logo-vector-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299835-solid-biosciences-to-participate-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Solid Biosciences to Participate at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299849-valitor-announces-oral-presentation-at-the-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299853-route-92-medical-announces-50-million-growth-financing</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Route 92 Medical Announces $50 Million Growth Financing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/526036da-ddbe-4a9a-9222-9570f7cd6544/small/r-rt92-logo-rbg0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299871-akebia-therapeutics-to-conduct-investor-meetings-at-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299961-aclarion-highlights-growing-adoption-of-nociscan-at-the-london-clinic-with-new-physician-video</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300025-calidi-biotherapeutics-announces-speaker-presentation-at-asgct-conference-in-boston-on-may-14-2026-highlighting-the-redtail-platform-s-ability-to</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300073-corbus-pharmaceuticals-announces-broad-alignment-with-fda-on-registration-path-for-crb-701-in-second-line-hnscc-and-cervical-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300089-liquidia-corporation-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300151-electrocore-announces-first-patient-enrollment-in-investigator-led-study-of-gammacore-nvns-for-ptsd</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300354-jupiter-neurosciences-appoints-kristopher-fishman-and-sanjiv-lal-to-nugevia-advisory-board</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300403-polyrizon-ltd-announces-3-5-million-registered-direct-offering-and-private-placement</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T12:00:00+00:00</news:publication_date>
        <news:title>Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/N2M3NTE1MmItYWFmMi00MDNlLWE4MTItMWIxMDg4MWYwMTRlLTUwMDEyOTIyMy0yMDI2LTA0LTA3LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300175-artelo-biosciences-regains-compliance-with-nasdaq-listing-requirements</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:50:00+00:00</news:publication_date>
        <news:title>Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299627-marvel-biosciences-secures-financial-and-strategic-investment-with-5-horizon-ventures</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d49e32dc-88d9-4694-a3dd-6e663548e80d/small/picture1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299632-anavex-life-sciences-to-present-at-the-25th-annual-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1b0f858f-4f7f-4f50-b691-a25307283fb5/small/anavexlogor-transparent-3x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299759-everbright-health-announces-ai-enabled-platform-to-unlock-access-to-advanced-mental-health-interventions</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2ce4a623-23ed-4e51-9115-db1f2526bcfc/small/everbrighthealth-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299841-plus-therapeutics-receives-ama-pla-code-for-cnside-csf-tumor-cell-enumeration-test-advancing-reimbursement-and-u-s-commercial-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904299993-cognition-therapeutics-to-present-at-needham-virtual-healthcare-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Cognition Therapeutics to Present at Needham Virtual Healthcare Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300070-palvella-therapeutics-appoints-accomplished-commercial-leader-kent-taylor-as-senior-vice-president-of-sales</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300109-cervomed-to-provide-neflamapimod-clinical-program-update-and-participate-in-a-panel-on-biomarkers-at-2026-lewy-body-dementia-association-annual</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300157-nervgen-pharma-announces-successful-end-of-phase-2-meeting-and-fda-alignment-on-restore-a-phase-3-registrational-study-of-nvg-291-for-chronic</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb42d0ef-06b6-4b90-8389-ca991092aa37/small/nervgen-logo-updated-globenewswire-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904300328-weight-watchers-appoints-lisa-gavales-and-sue-gove-to-board-of-directors</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:30:00+00:00</news:publication_date>
        <news:title>Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290412-pluristyx-extends-patent-portfolio-in-universal-cell-therapy-with-new-u-s-patent-for-iact-stealth-technology</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:09:00+00:00</news:publication_date>
        <news:title>Pluristyx Extends Patent Portfolio in Universal Cell Therapy with New U.S. Patent for iACT Stealth™ Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/22e38345-b052-4cc3-a4c3-556e798109f3/small/pluristyx-logo-blue-apr22-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290254-fennec-pharmaceuticals-announces-investigator-sponsored-study-to-be-conducted-by-university-of-arizona-cancer-center</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:03:00+00:00</news:publication_date>
        <news:title>Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290176-invivyd-launches-antibodies-for-any-body-in-partnership-with-world-champion-skier-lindsey-vonn-to-inspire-actions-that-help-support-immune-health</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:01:00+00:00</news:publication_date>
        <news:title>Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290028-ac-immune-announces-amendment-to-morphomer-tau-license-and-collaboration-agreement-with-lilly</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290055-mediwound-to-present-new-escharex-data-at-leading-wound-care-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>MediWound to Present New EscharEx® Data at Leading Wound Care Conferences </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290057-radiopharm-theranostics-and-siemens-healthineers-sign-clinical-supply-agreement-for-rad101-in-the-u-s</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/8e246920-183e-46a4-b13c-a3c9ec50ada9/small/radx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290245-sionna-therapeutics-to-participate-in-the-raymond-james-2026-biotech-innovation-symposium</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290255-soleo-health-relocates-denver-specialty-pharmacy-to-support-continued-growth</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Soleo Health Relocates Denver Specialty Pharmacy to Support Continued Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b3c4bcdc-fa25-4f50-8b81-09f13e80a008/small/soleo-logo-1024-x-1024-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290282-breckenridge-distillery-introduces-honey-whiskey-crafted-with-rare-nigerian-goldswarm-honey-a-must-try-for-whiskey-enthusiasts</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cb623008-0c9a-49db-ab38-6e3062dd8bdb/medium/breckenridge-distillery-honey-whiskey.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290354-climb-bio-announces-fda-fast-track-designation-for-budoprutug-for-the-treatment-of-primary-membranous-nephropathy</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290361-skye-bioscience-presenting-at-glp-1-based-therapeutics-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290381-nurix-therapeutics-to-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Nurix Therapeutics to Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290410-fortrea-unveils-fortrea-intelligent-technology-to-help-sponsors-and-sites-run-smarter-more-integrated-trials</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9fbbe00b-8782-464e-83e6-5843c563884a/small/fortrea-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290597-neuronetics-comments-on-letter-from-pointillist-family-office</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Neuronetics Comments on Letter from Pointillist Family Office</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290600-okyo-pharma-announces-scientific-advisory-board-meeting-and-urcosimod-data-presentation-during-ascrs-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290602-vantage-hemp-co-engages-acos-and-gpos-to-advance-participation-in-cms-cbd-pilot-program</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T11:00:00+00:00</news:publication_date>
        <news:title>Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d38e4562-945b-4df7-8869-623c43be10f1/medium/inside-vantages-manufacturing-facility.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290206-ani-pharmaceuticals-announces-publication-of-new-day-clinical-trial-results-in-ophthalmology</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:50:00+00:00</news:publication_date>
        <news:title>ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904290397-bluejay-diagnostics-inc-announces-completion-of-624-patient-enrollments-in-symon-ii-pivotal-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:30:00+00:00</news:publication_date>
        <news:title>Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904280802-serina-therapeutics-to-present-at-the-5th-lnp-formulation-process-development-summit</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Serina Therapeutics to Present at the 5th LNP Formulation &amp; Process Development Summit</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f8e4304-8465-4d4d-a7e3-ebc4eae51f29/small/yellow-burts-blue-text-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904280810-ascellahealth-named-to-financial-times-americas-fastest-growing-companies-2026-list</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5278c55f-330c-41a1-8446-d8b1a07bbc55/small/ah-logo-colornotag-4x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.healthcarejournalguam.com/article/904280821-greenwich-lifesciences-provides-update-on-patent-claims-potentially-doubling-gp2-market-potential</loc>
      <news:news>
        <news:publication>
          <news:name>Healthcare Journal Guam</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-07T10:00:00+00:00</news:publication_date>
        <news:title>Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
